To address this critical knowledge gap, the present study aimed to systematically evaluate the clinical relevance and prognostic significance of BRIP1 mRNA expression in CRC by integrating transcriptomic data from The Cancer Genome Atlas (TCGA) with analyses of tumor tissues obtained from an independent cohort of 60 CRC patients [15,16]. The gene discussed is BRIP1; the disease is colorectal carcinoma.